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Abstract
The integrative analysis of high‐throughput reporter assays, machine learning, and
profiles of epigenomic chromatin state in a broad array of cells and tissues has the
potential to significantly improve our understanding of noncoding regulatory element
function and its contribution to human disease. Here, we report results from the
CAGI 5 regulation saturation challenge where participants were asked to predict the
impact of nucleotide substitution at every base pair within five disease‐associated
human enhancers and nine disease‐associated promoters. A library of mutations
covering all bases was generated by saturation mutagenesis and altered activity was
assessed in a massively parallel reporter assay (MPRA) in relevant cell lines. Reporter
expression was measured relative to plasmid DNA to determine the impact of
variants. The challenge was to predict the functional effects of variants on reporter
expression. Comparative analysis of the full range of submitted prediction results
identifies the most successful models of transcription factor binding sites, machine
learning algorithms, and ways to choose among or incorporate diverse datatypes and
cell‐types for training computational models. These results have the potential to
improve the design of future studies on more diverse sets of regulatory elements and
aid the interpretation of disease‐associated genetic variation.
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1 | INTRODUCTION
Gene regulatory variants are known to play an important role in a
number of common human diseases, including diabetes, neuropsy-
chiatric disorders, autoimmune disorders, cardiovascular disease, and
cancer. Although some disease‐relevant variants have been identified
and thoroughly characterized, this set provides insufficient data to
test computational methods that aim to find such variants. Gene
regulatory variants modulate the strength of interactions between
enhancers and promoters and the transcription factors (TFs) that
bind them, and alter the cell‐specific transcriptional control of gene
regulatory networks central to the proper development and
functioning of human cells and tissues. Although we have a good
basic understanding of the general molecular mechanisms of these
interactions, quantitative and predictive models of cell‐specific
enhancer and promoter function are currently under active
development.
Blind community assessments provide the most principled way to
gauge the performance of the leading computational prediction models.
The 2016 Critical Assessment of Genome Interpretation (CAGI 4) eQTL
challenge (Beer, 2017; Kreimer et al., 2017; Tewhey et al., 2016; Zeng,
Edwards, Guo, & Gifford, 2017) assessed the effect of common human
variation on the enhancer activity in lymphoblast cell lines. It established
that the top performing state‐of‐the‐art models of the enhancer activity
typically used machine learning methods e.g. gkm‐SVM (Ghandi, Lee,
Mohammad‐Noori, & Beer, 2014; Lee et al., 2015), DeepBind (Alipanahi,
Delong, Weirauch, & Frey, 2015), and/or DeepSEA (Zhou & Troyanskaya,
2015)) using features learned from epigenomic chromatin state data
(DHS‐seq, Histone modification ChIP‐seq, TF ChIP‐seq, or ATAC‐seq) to
build models of TF binding specificity (Beer, 2017; Kreimer et al., 2017;
Zeng et al., 2017). Here, we significantly extend the earlier CAGI 4 study,
and report the results of the 2018 CAGI 5 regulation saturation
challenge. In this study, computational groups were asked to submit the
predicted impact on expression for every possible base pair mutation
within nine disease associated promoters (including TERT, LDLR, F9,
HBG1) and five disease‐associated enhancers (including IRF4, IRF6, MYC,
SORT1) tested by massively parallel reporter assay (MPRA) in one of
eight specified cell types (Kircher et al., 2018). This study expands on the
CAGI 4 assessment in two key aspects. First, although the CAGI
4 assessments were all in the GM12878 lymphoblast cell line, the CAGI
5 assessment separately tests a wider range of elements (promoters and
enhancers) in multiple disease‐relevant cell types. Second, the CAGI 4
assessments tested common SNPs linked to GM12878 eQTLs, whereas
the current CAGI 5 assessment mutates numerous bases in the 14
elements tested. This approach has the advantage that saturation
mutagenesis can test mutations that are not common variants in the
human population, are not subject to selection, and thus potentially have
a larger impact on the enhancer or promoter activity, whether positive or
negative.
Although the CAGI 4 regulation variation experiment established
that machine learning models can predict MPRA experiments with
moderate precision, the current CAGI 5 experimental design allows
us to address some additional fundamental questions, which we hope
will be used to improve future experiments to investigate human
gene regulatory disease variants. The GM12878 cell line used in
CAGI 4 is one of the most well‐covered cell lines in the ENCODE
epigenomic data sets, so the training data available was already well
utilized by previously published models. The CAGI 5 assessment in
multiple cell lines is thus potentially more challenging in terms of
model training, because of the more diverse selection of cell types.
One of our primary results is that multiple groups presented
successful ways to incorporate multiple functional datasets of
different types into the prediction models. In addition, we can ask
to which degree promoters and enhancers have shared or distinct
regulatory vocabularies (within the limitations of the sample size),
and whether different training designs should be adopted for testing
promoters versus distal enhancer regulatory variants.
2 | REGULATION SATURATION
CHALLENGE
In theMPRA assay, the activity of the enhancer elements is characterized
by a reporter assay linking a candidate enhancer sequence to a minimal
promoter and a reporter gene whose 3′‐untranslated region includes a
unique sequence tag. The reporter vectors are introduced into cell lines
as plasmids, and the reporter gene expression for each variant is
examined relative to the amount of its plasmid DNA, which is variable
because different elements tested have varying rates of synthesis and
transfection. If the candidate sequence acts as an enhancer, it will
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increase promoter activity and the reporter gene expression in the tissue/
cell type of interest. Like enhancers, promoter candidate sequences are
also cloned into a plasmid upstream of a tagged reporter (without an
additional minimal promoter), and reporter expression is measured as
RNA relative to the plasmid DNA to determine the impact of promoter
variants.
The underlying MPRA libraries (50k‐2M) were derived from
saturation mutagenesis of regulatory regions of up to 600 bp length.
Changes to functional sequences from the template sequence with a
rate of 1 per 100 bases were created by error‐prone PCR, and the
resulting PCR products were integrated into plasmid libraries containing
random tag sequences. High‐throughput sequencing was carried out to
determine the tag association with the introduced enhancer/promoter
sequence variants (Inoue & Ahituv, 2015; Patwardhan et al., 2012).
Promoter and enhancer libraries were transfected into a cell line
relevant to the disease phenotype (Table 1). Across three transfection
replicates, RNA and DNA was collected and sequenced. The relative
abundance of each transcribed RNA tag count in relation to DNA tag
counts of the transfected plasmid library provides a digital readout of
the transcriptional efficiency of the cis‐linked mutant promote or
enhancer. Specifically, a multiple linear regression model of log2(RNA) ~
log2(DNA) +N+ offset (where RNA and DNA are counts observed for
all tags, N is a binary matrix associating tags to sequence variants, and
offset normalizes total DNA to RNA counts) was used to assign
sequence effects. From this fit, coefficients (corresponding to the
columns of matrix N) were assigned as the effects of each sequence
variant. The coefficient/regression weight for a given nucleotide can
be interpreted as the degree to which it contributes to the gene
expression. A more detailed description of the MPRA experimental
methods is given in (Kircher et al., 2018).
Participant groups were given the impact of the variants in selected
subsets from each region to train their models, consisting of 25% of the
sequence, and the remaining 75% of the sequence regions were used for
evaluation. An example of the training regions selected and the
expression impact for each base is shown in Figure 1 for SORT1, and
for all regions tested in Figure S1. Although the reference sequence
strand is shown, in all cases the experiment preserved the wild‐type
orientation of the sequence relative to the TSS, as indicated. The 25%
training data is indicated in yellow. The participants were to submit a
label of +1 to the variants in the testing set if there was a significant
upregulating effect, −1 for a significant downregulating effect, or 0 for
very little to no effect on expression. Because of the imprecise
interpretation of what a “significant” effect could mean, we used as a
primary metric of evaluation the Pearson correlation of the predicted
labels (−1,0,1) with the continuous MPRA expression impact scores. We
also calculated the AUROC treating this as a discretized classification
task (1 vs −1, or 1 vs (0 and −1), or −1 vs (0 and 1), and so forth), but the
relative ranking of prediction methods using correlation or AUROC were
very similar. In retrospect, the discretization of predictions into three
classes (−1,0,1) limited the sensitivity of our model comparisons. For our
detailed comparisons among the top models, we asked participants to
submit continuous prediction scores for their best‐performing models.
Each group was allowed to submit multiple separate prediction sets from
different models.
3 | RESULTS
Seven groups submitted multiple prediction methods, as described in
detail in Methods. Most groups used a combination of epigenomic
TABLE 1 Regions tested
Promoters
Region hg19 coords hg38 coords Length Cell line
F9 chrX:138612624–138612923 chrX:139530465–139530764 300 HepG2
GP1BB chr22:19710790–19711173 chr22:19723267–19723650 384 HEL 92.1.7
HBB chr11:5248252–5248438 chr11:5227022–5227208 187 HEL 92.1.7
HBG1 chr11:5271035–5271308 chr11:5249805–5250078 274 HEL 92.1.7
HNF4A chr20:42984160–42984444 chr20:44355520–44355804 285 HEK293T
LDLR chr19:11199907–11200224 chr19:11089231–11089548 318 HepG2
MSMB chr10:51548988–51549578 chr10:46046243–46046833 591 HEK293T
PKLR chr1:155271187–155271655 chr1:155301396–155301864 469 K562
TERT chr5:1295105–1295362 chr5:1294990–1295247 258 HEK293T, GBM
Enhancers
Region hg19 coords hg38 coords Length Cell line
IRF4 chr6:396143–396593 chr6:396143–396593 451 SK‐MEL‐28
IRF6 chr1:209989135–209989734 chr1:209815790–209816389 600 HaCaT
MYC chr8:128413074–128413673 chr8:127400829–127401428 600 HEK293T
SORT1 chr1:109817274–109817873 chr1:109274652–109275251 600 HepG2
ZFAND3 chr6:37775276–37775853 chr6:37807500–37808077 578 MIN6
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state features (ENCODE DHS‐seq, Histone modification ChIP‐seq, TF
ChIP‐seq, and methylation, established marks of promoter and
enhancer activity) and DNA sequence‐based features (Position
Weight Matrices, PWMs, for known TFs from databases, DeepSEA,
and DeepBind scores from training machine learning methods to
predict ENCODE accessibility and binding, evolutionary
conservation, or constraint, kmers, DNA shape, and AT/GC content)
to train their models. The conceptual challenge was how to best
combine these diverse features to make predictions, and most groups
used tree‐based classifiers to learn the proper weighting of which of
the features best predicted the impact of the mutations in the
training data. The classes of prediction features used by each group
are summarized in Figure 2. Different methods submitted by each
group used slight variations of learning methods or combined feature
subsets, so the broad set of methods submitted and wide range of
performance allowed us to compare subsets of prediction methods to
assess the informative value of different feature identification
methods, or different feature subsets or feature selection methods.
The Pearson correlation between the discretized predictions
(−1,0,1) and the MPRA expression impact for all regions are shown in
Figure 3 and Table S1. A few submissions were late by a few minutes
and are labeled ‘L’ but were fully included in the evaluation. Although
there was some variability across regions, the top three methods G3/
1, G5/5‐7, and G7/3 L had average correlation C = (0.308, 0.255, and
0.318), respectively. Predictions for G5/5‐7 were indistinguishable.
The distinguishing feature of the top three performing methods is
that they all used DNA sequence features derived from Deep Neural
Networks (DNN) trained on ENCODE data (DeepSEA or similar
network methods). Thus one of the main conclusions of this study is
that machine learning‐based DNA sequence features are the best
predictors of mutation impact in enhancers and promoters,
consistent with our previous findings (Beer, 2017; Inoue et al.,
2017; Kreimer et al., 2017; Lee et al., 2015). The top three groups all
did particularly well on F9 and TERT‐GBM, which we will discuss
below. None of the methods used gapped‐kmer features, which have
advantages (Ghandi, Mohammad‐Noori, & Beer, 2014) relative to
full‐length kmers, which were used by groups G2 and G7. As
discussed below, gkm‐SVM also performed as well as the top
submitted methods, which allowed us to use gkm‐SVM (Ghandi, Lee
et al., 2014) and deltaSVM (Lee et al., 2015) as a previously published
benchmark method for comparison, and to evaluate which design
choices and subsets of ENCODE training data are most informative
without retraining the submissions from the various groups.
F IGURE 1 MPRA expression data for the SORT1 enhancer. The
expression impact of each of the three mutations of each base in the
600 bp enhancer is shown. Clusters of negative impact regions occur
near TFBS, which can be disrupted in many ways. Isolated positive
impact regions indicate rare creation of TFBS. Training regions
indicated in yellow. MPRA, massively parallel reporter assay
F IGURE 2 Summary of features used by prediction groups
F IGURE 3 Overview of challenge results. The Pearson
correlation between the discretized predictions (−1,0,1) and the
MPRA expression impact for all regions (promoters labeled in black,
enhancers labeled in red) and average correlation over all regions.
The top three methods G3/1, G5/5‐7, and G7/3 L had an average
correlation C = (0.318, 0.255, and 0.318), respectively. MPRA,
massively parallel reporter assay
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To assess the predictive value of different types of features, we
plot the average correlation of methods using a given feature in
Figure 4 across all regions tested. We averaged the correlation of the
best submission from each group using a given feature, as long as it
was used by at least two groups. We included G3/1‐3 because these
methods used distinct features, which informed our assessment of
relative performance. Methods which used DNN derived features
(DeepSEA) tended to produce the best performance on average
(C = 0.29). Groups 3 and 7 used the 919 delta P outputs from
DeepSEA as features, and Group 5 used features from a neural
network modeled similar to DeepSEA in training and network
structure (Hawkins‐Hooker, Kenlay, & Reid, 2018).
After the challenge submission closed, our preliminary analysis
indicated that group‐to‐group differences in assigning cutoffs for the
discretized prediction classes were in some cases limiting the
robustness of our comparisons, so we asked the three groups with
the best‐performing methods to submit continuous scores, and
reevaluated these continuous predictions, as shown in Figure 5 and
Table S1. The Pearson correlation with continuous scores was
significantly higher for all three methods, average correlation
(C = 0.45, 0.28, 0.45) for method G3/1, G5/5‐7, and G7/3 L,
respectively. This presents a significant improvement relative to a
previously published Method CADD (Kircher et al., 2014), which had
C = 0.11.
We compared these three top‐performing submissions to the
previously published method, deltaSVM. Comparison of the leading
three prediction groups indicated the important classes of features,
and each leading group arrived at a similar method to successfully
combine features from different cell types using the training data.
The use of deltaSVM allows us to explore the effects of different
training datasets and experimental design choices in more detail
without having to retrain the submitted models. deltaSVM is usually
trained on histone ChIP‐seq, DHS‐seq, ATAC‐seq, or TF ChIP‐seq
data from a single cell type. After this approach, we chose the most
closely matched cell line DHS‐seq data set from ENCODE for all cell
lines tested (HepG2, K562, HEK293, NHEK, Melano), except MIN6,
for which we used ATAC‐seq data from (Kycia et al., 2018), and
trained gkm‐SVM to determine sequence features. We then
generated deltaSVM scores for each locus using the appropriate
cell‐specific trained gkm‐SVM model. As shown in Figure 5, deltaSVM
(dSVM) with discretized predictions trained on only DHS‐seq from
one cell type was slightly less accurate than the best performing
models G3, G5, G7 (C = 0.30). To discretize the deltaSVM scores for a
fair comparison, we used z‐score > 1 for class + 1, z‐score < −1 for
class −1, and all others class 0. We then compared continuous scores
from deltaSVM trained on DHS from one cell type, and performance
improved, but it was still somewhat below the best performing
submissions (C = 0.38). After the innovation introduced by the best
prediction methods (groups 3, 5, and 7), we hypothesized that
deltaSVM predictions could be improved further if we combined
deltaSVM scores identified from models trained on more than one
ENCODE data set. We trained gkm‐SVM independently on all
available ENCODE (DHS, histone, and TF datasets, 3,350 datasets
F IGURE 4 Average performance of various feature sets. We
averaged the correlation of the best submission from each group
using a given feature, as long as it was used by at least two groups.
Methods which used DNN derived features (DeepSEA) tended to
produce the best performance on average (C = 0.29). DNN, deep
neural networks
F IGURE 5 Continuous Scores Comparison. The correlation of the
top three submissions was higher using continuous prediction scores
(C = 0.45, 0.36, 0.45). We also compared with deltaSVM (dSVM) with
discretized scores (C = 0.30) and continuous scores (C = 0.39) when
trained on DHS from one cell type. Following the method used by the
top three groups, combining deltaSVM scores from multiple
epigenomic datasets with a RF or Lasso improved the performance
to C = 0.40. Using a 50‐50 training/test split increased the multiple
datatype trained deltaSVM RF and Lasso performance dramatically
to C = 0.578 and 0.562, respectively. RF, random forest
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total, and trained separate models for the DHS and histone promoter
and enhancer peaks), and then used both a Random Forest (RF) and
Lasso classifier to learn which combinations of deltaSVM features
best predicted the training mutation impact data. We evaluated the
model on the held out test set. Combining deltaSVM scores from
multiple epigenomic datasets with a RF or Lasso improved the
performance slightly to C = 0.40. We further noticed that some of
the regions which did poorly (MYC and HNF4a) had sparse training
data, and to detect the proper feature importance, relevant binding
sites should be disrupted in the training data. We then used a
randomly sampled 50‐50 training/test split to train the deltaSVM RF
and Lasso models, and this increased performance dramatically to
C = 0.578 and 0.562 (averaged over 10 randomly sampled splits,
standard deviation = 0.046), as shown in Figure 5 and Figure S2. The
most informative datasets for deltaSVM training as selected by the
Lasso model are listed in Table 2. The most commonly selected
ENCODE datasets were DHS and TF ChIP‐seq. Training gkm‐SVM on
these datasets yield sequence features which in combination are
most able to reproduce the training data. The weighted combination
of these features in either the RF or Lasso model is also the most
predictive model of test set mutation impact, as shown in Figure 5.
These comparisons motivated a simpler method to compare the
importance of DNA sequence features trained in all ENCODE data
types, and assess their comparative informative value for predicting
the impact of mutations in each MPRA experiment. Although
selection in the RF model is one measure of importance, more
simply, we can learn deltaSVM scores trained on one ENCODE
datatype in one cell‐type or tissue, and calculate the correlation of
these deltaSVM scores with mutation impact across each locus one
at a time. The range of correlation for deltaSVM models trained on
DHS (enhancer and promoter, e&p), H3K27ac (e&p), H3K4me1
(e&p), H3K4me3 (e&p), and TF ChIP‐seq (all peaks) is shown in
Figure 6 and Figure S3. For the TERT‐GBM promoter, DHS promoter
deltaSVM scores are most highly correlated with expression impact,
followed by select TF ChIP‐seq datasets. It is noteworthy that the
range of correlation across all DHS promoter trained models is quite
narrow, indicating that models trained on DHS promoters from any
cell type are quite good at predicting mutation impact at the
TERT‐GBM promoter, and implying that promoter regulatory
vocabulary might be less dependent on cell type. The same is not
true of enhancers (SORT1), only a few cell‐types yield high
correlation, indicating that enhancer regulatory vocabulary is more
cell‐specific. To quantify this, in Figure 6c,d we show the mean
correlation versus best correlation of DHS enhancer trained models
and promoter trained models for all regions tested. The best
performing promoter regions have significantly higher mean across
all ENCODE promoter datasets, indicating that promoter
performance is less dependent on training on a matched cell type,
whereas enhancer performance is only high for a few matched cell
types. Also interesting is that H3K27ac deltaSVM scores are
systematically less predictive of mutation impact at both enhancers
and promoters. In addition, although H3K4me3 is a promoter‐specific
mark, deltaSVM trained on H3K3me3 at promoters was only weakly
correlated with promoter mutation impact. The informative value of
H3K4me1 derived enhancer features was also weaker than DHS and
TFs. A subset of deltaSVM scores derived from TF ChIP‐seq data
were among the most informative marks at both promoters and
enhancers (see Table 2 and 3), but the range of ENCODE TF
ChIP‐seq datasets correlated with promoter MPRA impact was larger
than at enhancers, implying that within the ENCODE TF ChIP‐seq
compendium are many TFs that bind at promoters. One of these is
RNA Polymerase II, which is among the frequently ChIP‐ed factors.
The list of the ENCODE datasets whose deltaSVM scores were most
highly correlated with mutation impact in each region tested is listed
in Table 3. These simple correlation measures are largely consistent
with the top Lasso selected deltaSVM features in Table 2. Among the
most correlated datasets for deltaSVM training on promoters, five
were enhancer DHS (17%), four were promoter DHS (13%), and 21
were TF ChIP‐seq (70%). Among the most correlated datasets for
deltaSVM training on enhancers, eight were enhancer DHS (53%) and
seven were TF ChIP‐seq (47%).
To investigate whether the contiguous bases in the training
regions provided in the CAGI 5 experimental design could affect the
detection of TFBS, we compared the performance of the deltaSVM
RF and Lasso models trained on randomly selected bases versus
training sets of equal size with no contiguous bases. In the latter case,
we used a regular mask, eg. 000100010001…, to select bases for
inclusion in the training set, in this case, 25% training, and repeated
four times with each possible phasing. In Figure S4 we compare
performance for training ratios 1:1, 1:2, 1:3, 1:4, 1:5, and 1:6 with
random or regularly masked training set selection. Although
performance dropped with reduced training set size, regularly spaced
training sets performed slightly better than randomly selected
training sets of equal size, presumably because there is more uniform
coverage of TFBS disruption in the regular training sets, and more
clustering in the random sets. However, this small difference in
performance did not scale with the spacing between bases, as one
might expect if neighboring bases within a TFBS were influencing
performance.
4 | DISCUSSION
This MPRA computational challenge yielded several useful results.
On the experimental side, saturation mutagenesis generated a
broad range of mutation impact which allowed clear distinction
among competing computational methods. Each region tested had
negative impact scores, which reflected the disruption of clusters
of multiple (~5‐8) binding sites, and our impression from the
success of these comparisons is that the longer regions tested in
this experiment might more closely reflect the function of these
regions in their native genomic context than experiments with
shorter inserts. In terms of future challenge design, we recommend
that continuous prediction scores be used for all assessments. The
requested prediction confidence scores were difficult to incorpo-
rate into our analysis.
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Comparisons of the computational predictions revealed addi-
tional important insights for understanding enhancer/promoter
function and how to build more accurate models of their role in
human disease. All top performing models for mutation impact
prediction used machine learning based DNN (or gkm‐SVM) DNA
sequence features trained on chromatin accessibility or chromatin
state data. These models consistently outperformed models using
sequence features derived from other sources: PWMs from existing
databases, evolutionary conservation, kmers, or more generic
sequence features (eg. GC content). The machine learning‐based
models also outperformed models using chromatin accessibility,
chromatin state, or TF ChIP‐seq data without using the epigenomic
data to derive DNA sequence‐based models. When the machine
learning‐based DNA sequence features are combined with proper
importance weighting derived from another layer of machine
learning on a subset of the mutation data used as training for each
cell type, the overall prediction accuracy is high. Although we have
shown that gapped‐kmer features are equally or more informative
than DNN‐based features, we emphasize that deltaSVM was not
evaluated in a blind prediction, but only after the challenge, as part of
the model assessment. Although most of the 15 different experi-
ments were well predicted, there was significant variation. MSMB,
HNF4a, and MYC were the most difficult to predict, which may be
because of the quality of the MPRA data for these experiments or
biological characteristics of these sequences, such as the density of
binding sites, or the specific genomic sequence interval tested.
TABLE 2 Most informative ENCODE datasets by incorporation into deltaSVM Lasso model. Datasets that were given non‐zero regression
coefficients for each region when searching for at most ten non‐zero coefficients using LASSO across multiple training and testing 50‐50 data
splits
F9 (HepG2) LDLR (HepG2) IRF4 (SK‐MEL‐28)
HepG2: ETV4 ChIP‐seq MCF‐7: SREBF1 ChIP‐seq SK‐MEL‐5: DHS enhancers
HepG2: 3xFLAG‐KAT8 ChIP‐seq HepG2: 3xFLAG‐SP5 ChIP‐seq foreskin melanocyte: DHS enhancers (Roadmap)
K562: FOXK2 ChIP‐seq HEK293: eGFP‐SP3 ChIP‐seq GM12878: RAD51 ChIP‐seq
K562: ZNF592 ChIP‐seq HEK293: ZNF263 ChIP‐seq GM12878: ATF7 ChIP‐seq
HepG2: ZHX2 ChIP‐seq HepG2: 3xFLAG‐ZNF652 ChIP‐seq HT1080: DHS enhancers (Roadmap)
GP1BB (HEL 92.1.7) MSMB (HEK293T) IRF6 (HaCaT)
K562: GABPB1 ChIP‐seq HEK293: eGFP‐PRDM6 ChIP‐seq foreskin keratinocyte: DHS enhancers (Roadmap)
CMK: DHS enhancers K562: ATF2 ChIP‐seq bronchial epithelial cell: DHS enhancers
K562: GATA2 ChIP‐seq adrenal gland female embryo: DHS enhancers
(Roadmap)
keratinocyte: DHS enhancers
MCF‐7: eGFP‐KLF9 ChIP‐seq HeLa‐S3: DHS enhancers Peyer’s patch: DHS enhancers
K562: GABPA ChIP‐seq mesenchymal stem cell: DHS enhancers K562: ATF2 ChIP‐seq
HBB (HEL 92.1.7) PKLR (K562) MYC (HEK293T)
HEK293: eGFP‐SP2 ChIP‐seq K562: DHS enhancers HeLa‐S3: CTCF ChIP‐seq
L1‐S8R: DHS enhancers MCF‐7: eGFP‐KLF9 ChIP‐seq HepG2: RAD21 ChIP‐seq
K562: NFYB ChIP‐seq liver embryo: DHS enhancers CWRU1: DHS enhancers
liver embryo: DHS enhancers K562: DPF2 ChIP‐seq A549: SMC3 ChIP‐seq
K562: DHS enhancers K562: eGFP‐ZNF148 ChIP‐seq K562: MAZ ChIP‐seq
HBG1 (HEL 92.1.7) TERT (GBM) SORT1 (HepG2)
GM12878: NFYB ChIP‐seq HepG2: GABPA ChIP‐seq HepG2: CEBPB ChIP‐seq
HEK293: eGFP‐KLF1 ChIP‐seq CMK: DHS enhancers HepG2: FOXA1 ChIP‐seq
K562: NFYB ChIP‐seq HepG2: 3xFLAG‐SP5 ChIP‐seq K562: eGFP‐ZNF148 ChIP‐seq
HL‐60: DHS enhancers heart left ventricle: DHS enhancers HepG2: KDM1A ChIP‐seq
K562: IRF1 ChIP‐seq TH17: DHS promoters HepG2: TCF7 ChIP‐seq
HNF4A (HEK293T) TERT (HEK293T) ZFAND3 (MIN6)
K562: NFYB ChIP‐seq K562: GABPB1 ChIP‐seq adrenal gland: DHS enhancers A549: USF1 ChIP‐
seq
K562: EGR1 ChIP‐seq HepG2: GABPA ChIP‐seq brain embryo: DHS enhancers (Roadmap)
K562: eGFP‐ZFX ChIP‐seq HepG2: 3xFLAG‐GABPA ChIP‐seq SK‐N‐SH: RFX5 ChIP‐seq
HEK293: eGFP‐KLF9 ChIP‐seq CMK: DHS promoters cerebellar cortex: DHS enhancers
MCF‐7: eGFP‐KLF9 ChIP‐seq K562: eGFP‐ETV1 ChIP‐seq Ammon’s horn: DHS enhancers
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Following the three most successful prediction models, we
designed a method to combine gkm‐SVM features derived from
multiple ENCODE datatypes to predict the impact of mutations in
cell type specific promoters and enhancers. This analysis
demonstrates that combining DNA sequence features trained from
multiple cell and datatypes improves the accuracy of mutation impact
prediction, even if the cell types are not perfect matches to the cell
type used in the MPRA. DHS alone does not produce optimal
performance. This comparison with deltaSVM allowed us to assess
the relative informative value of features derived from different cell
types and different ENCODE assays. We found that DHS derived
features were most informative, but that the integration of TF
ChIP‐seq derived features significantly improved performance. The
question of which TFs to include in this computational exercise was
addressed by using a training subset of the mutation data. For
computational model assessment, this is an effective experimental
design, but for future disease studies, where training data is
unavailable, averaging mutation impact scores for DHS and known
relevant and available TF ChIP‐seq derived models in the cell type of
interest is probably the best approach. Identifying which TFBS are
learned in the DNN or gkm‐SVM weights and using ChIP‐seq data for
these TFs is another possible approach.
We also found evidence of somewhat distinct TF vocabulary at
enhancers and promoters: Promoter DHS trained feature models
predicted promoters better, and enhancer DHS trained feature
models predicted enhancers better. This suggests that separate
training of peaks in enhancers and promoters is advantageous, and
raises the potential concern that predictions on the basis of models
F IGURE 6 Correlation of deltaSVM scores trained on all ENCODE datasets with MPRA expression impact. In one promoter (a) TERT‐GBM
and one enhancer (b) SORT1, the full range of correlation of deltaSVM scores with expression impact is shown for different training datatypes
(see Methods for a full description of datasets). (c,d) The correlation of deltaSVM scores with expression impact for the best single ENCODE
DHS enhancer (c) and promoter (d) datasets, compared with the mean across all ENCODE datasets of that type. Although only a few enhancer
datasets in relevant cell types yield high correlation, the mean performance for the best‐predicted promoters is much higher than for enhancers,
suggesting a more cell‐type independent promoter vocabulary. MPRA, massively parallel reporter assay
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TABLE 3 Most informative ENCODE datasets by correlation of deltaSVM scores with mutation impact
Promoters
Region Data set Rank Corr Description
F9 TF_E2_41 1 0.600 GAbisphenol A ChIP‐seq on ethanol treated A549
F9 TF_E3_346 2 0.592 ETV4 ChIP‐seq on human HepG2
F9 TF_E3_472 3 0.587 3xFLAG‐KAT8 ChIP‐seq on human HepG2
GP1BB TF_E2_274 1 0.414 GABPA ChIP‐seq on K562
GP1BB DHS_E2_95e 2 0.410 CMK
GP1BB DHS_E2_56e 3 0.398 K562
HBB DHS_E3_182p 1 0.500 hematopoietic multipotent progenitor cell
HBB DHS_E3_157p 2 0.494 L1‐S8R
HBB DHS_E2_1e 3 0.494 K562
HBG1 TF_E2_113 1 0.472 NFYB ChIP‐seq on human GM12878
HBG1 TF_E2_290 2 0.457 NFYB ChIP‐seq on human K562
HBG1 TF_E2_229 3 0.439 NFYA ChIP‐seq on human K562
HNF4A TF_E3_761 1 0.309 EGR1 ChIP‐seq on human K562
HNF4A TF_E2_233 2 0.305 EGR1 ChIP‐seq on human K562
HNF4A TF_E3_765 3 0.302 EGR1 ChIP‐seq on human K562
LDLR TF_E3_505 1 0.539 3xFLAG‐SP5 ChIP‐seq on human HepG2
LDLR TF_E3_234 2 0.510 eGFP‐SP3 ChIP‐seq on human HEK293
LDLR TF_E2_226 3 0.482 IRF1 ChIP‐seq on IFN treated human K562
MSMB DHS_E2_13e 1 0.362 fibroblast of villous mesenchyme
MSMB TF_E3_244 2 0.361 eGFP‐PRDM6 ChIP‐seq on human HEK293
MSMB TF_E3_267 3 0.332 eGFP‐ZNF629 ChIP‐seq on human HEK293
PKLR DHS_E2_1e 1 0.496 K562
PKLR DHS_E3_130e 2 0.495 liver embryo (59 days) and embryo (80 days)
PKLR TF_E2_345 3 0.492 TBL1XR1 ChIP‐seq on human K562
TERT‐GBM DHS_E2_95p 1 0.603 CMK
TERT‐GBM TF_E2_200 2 0.597 GABPA ChIP‐seq on human HepG2
TERT‐GBM DHS_E3_11p 3 0.585 PC‐3
TERT‐HEK293T TF_E3_666 1 0.554 GABPB1 ChIP‐seq on human K562
TERT‐HEK293T TF_E2_200 2 0.550 GABPA ChIP‐seq on human HepG2
TERT‐HEK293T TF_E3_407 3 0.547 3xFLAG‐GABPA ChIP‐seq on human HepG2
Enhancers
Region Data set Rank Corr Description
IRF4 DHS_E3_110e 1 0.581 SK‐MEL‐5
IRF4 DHS_RM_214e 2 0.574 foreskin melanocyte male newborn
IRF4 DHS_RM_14e 3 0.572 foreskin melanocyte male newborn
IRF6 DHS_E2_126e 1 0.356 bronchial epithelial cell ‐ retinoic acid
IRF6 DHS_E2_42e 2 0.351 keratinocyte female
IRF6 DHS_RM_17e 3 0.348 foreskin keratinocyte male newborn
MYC TF_E2_152 1 0.395 CTCF ChIP‐seq on human HeLa‐S3
MYC TF_E3_2 2 0.394 SMC3 ChIP‐seq on human A549
MYC TF_E2_188 3 0.39 RAD21 ChIP‐seq on human HepG2
SORT1 TF_E2_175 1 0.508 CEBPB ChIP‐seq on human HepG2
SORT1 TF_E3_401 2 0.498 SOX13 ChIP‐seq on human HepG2
SORT1 TF_E3_473 3 0.492 3xFLAG‐SOX13 ChIP‐seq on human HepG2
(Continues)
1288 | SHIGAKI ET AL.
trained on all sets of peaks without this distinction (like DeepSEA)
may yield predictions that are less accurate at describing mutations
in distal enhancer elements. Our results in Figure 5 show that the
groups using features trained on all peaks (DeepSEA or DNN) are
consistently better at predicting promoters, whereas deltaSVM
separately trained on enhancers and promoters shows better
performance than the submitted models on predicting mutation
impact at the five distal enhancers tested.
Although the current MPRA assays yield extremely useful tests of
base pair resolution cell‐specific DNA regulatory element activity,
these assays do not recapitulate the native 3D interactions between
regulatory elements, for example, enhancer‐promoter interactions,
which also impact transcriptional output and the impact of regulatory
mutations on human disease (reviewed, e.g., in (Bonev & Cavalli,
2016; Gorkin, Leung, & Ren, 2014)). These interactions do not appear
to be completely specified by features within single elements (Xi &
Beer, 2018) and modeling these interactions remains an active area
for future investigation.
5 | METHODS
Group 1: Selected features were taken from the following databases:
Combined Annotation Dependent Depletion (CADD; Kircher et al.,
2014), Functional Analysis through Hidden Markov Models v2.3
(FATHMM; Shihab et al., 2013), and ElemeNT (Sloutskin et al., 2015).
The prediction analyses were performed using WEKA 3.8 data mining
software. More than 100 data features were created and down-
loaded from the abovementioned collections. In the training data,
sequence variants that had a confidence level lower than 0.1 were
considered as 0 (“No Effect”) and variants that had a higher
confidence level were marked as either 1 (increase in expression
level) or −1 (decrease in expression level), on the basis of the sign of
the change in the expression value. In the first submission method,
the impact (−1,0,1) was predicted using a RF classifier on 27 features
from CADD and FATHMM. In the second submission, each variant
effect was predicted separately, that is one classifier tried to predict
which variants would cause upregulation, and another classifier tried
to predict which variants would cause downregulation. Both
predictions were combined in the following way: For a particular
variant in the testing set, if the labels of the classifiers were (0,0), 0
was assigned. If a variant’s pair of predictions was (−1,0) or (0,1), −1
or 1 was assigned, respectively. In the case of conflict between pairs
of labels (−1,1), the label with the highest prediction score was
chosen. Fifteen features were selected to predict which variants
cause downregulation and 11 features were used for upregulation
prediction.
Group 2: The training and test set variants were annotated using
features from WGSA v0.7 and CADD v1.3. In addition to capture
sequence context, 3‐mers and 5‐mers centered on a given position, along
with the mutated variant were included as additional categories. All
categorical features were one‐hot encoded. Imputation on missing values
was performed using k‐nearest neighbors (KNN, n=3) from the
“fancyimpute” python package. All models were implemented in Python
using “scikit‐learn” package. Model training was performed on the
estimated variant effect as labels, provided by the CAGI5 challenge
organizers (25% of the measured alleles). Submissions 1,2,3, and 5 utilized
multi‐class classification, and submission 4 used regression. For multi‐
class classification, three classes were defined on the basis of the
experimental variant effect value: −1 if value <−0.1; 1 if value > 0.1; else
0. Learning was performed using “XGBClassifier” and “XGBRegressor” in
the Python “xgboost” library. The hyperparameters for the xgboost
algorithm were optimized using a Bayesian implemented in the
“BayesSearchCV” class of the “scikit‐optimize” package. For submission
1, the optimal set of xgboost parameters was obtained by “Bayes-
SearchCV” using 100 iterations and three‐fold stratified cross‐validation.
In submission 1 (primary submission) and submissions 3–5, all the
training data was used irrespective of the different loci. In submission
2, the training set was first split by locus and different multi‐class
“xgboost” classifiers were trained and predicted separately. In
submission 3, the KNN imputation was performed on data from
each locus separately before training. In submission 4, the problem
was modeled as regression rather than multi‐class classification. In
submission 5, for all numeric features, the values were transformed
by a rolling mean of a window of five consecutive bases.
Group 3: For each variant in training and test data, features from
functional genomics data obtained by RegulomeDB (Boyle et al., 2012)
were either binary or numerical values. The binary features indicated
overlapping regions from ENCODE ChIP‐Seq peaks, ENCODE DNase‐
Seq peaks, TF motif matching using PWM’s, and DNase footprints.
Numerical features from ChIP‐Seq signals and information change of the
matched PWM were also used (these were used for all submissions). In
addition, submissions 1 and 4 used DeepSEA (Zhou & Troyanskaya, 2015)
features, submissions 2 and 5 used DeepBind (Alipanahi et al., 2015)
features, and submissions 3 and 6 used information change of all tested
PWMs. A RF classifier (500 trees) was used to predict the direction of
variant effects. The RF classifier also outputs a probability of prediction,
which was used to calculate continuous scores. For continuous scores, if
the predicted label was +1 or −1, the probability of +1 or −1, respectively,
was used as the continuous prediction (the continuous prediction was
TABLE 3 (Continued)
Enhancers
Region Data set Rank Corr Description
ZFAND3 DHS_RM_146e 1 0.397 brain female embryo (85 days)
ZFAND3 TF_E2_394 2 0.392 RFX5 ChIP‐seq on human SK‐N‐SH
ZFAND3 DHS_E3_166e 3 0.384 adrenal gland male adult (37 years)
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also given the same sign as the sign of the label). Otherwise, the
difference between the probability of +1 and the probability of −1 was
taken.
Group 4: This group used a DNN similar to DeepSEA trained on
ENCODE data, but used DeepLIFT (Shrikumar, Greenside, & Kundaje,
2017) to extract features and score mutation impact. Subsequent
neural network and SVM layers weighted these features using the
training data for impact prediction.
Group 5: The features used were conservation, DNase hypersen-
sitivity, and features generated from a neural network model similar
to DeepSEA in network structure (Hawkins‐Hooker et al., 2018).
Conservation scores were retrieved from phyloP (Pollard, Hubisz,
Rosenbloom, & Siepel, 2010), phastCons (Siepel et al., 2005), GerpN,
and GerpRS (Davydov et al., 2010). DNase hypersensitivity for each
regulatory element was determined by identifying the closest
matching ENCODE cell type for which there is a DNase‐hypersensi-
tivity track. For DeepSEA scores, several different neural network
architectures were trained on the basis of the genomic prediction
benchmark detailed in the original DeepSEA paper. This group
evaluated these networks on a region surrounding each variant
twice, once with the reference allele and once with the alternate
allele. Features were generated as the difference in activations
between the two evaluations of internal and output layers of the
networks. To predict the direction of change, this group used three
different gradient boosting algorithms: “XGBoost”, “CatBoost” and
“LightGBM”. The best features were determined by performing five‐
fold cross‐validation on different subsets of features. Models were
assessed by cross‐validating one against many area‐under‐precision‐
recall‐curve.
Group 6: Features were derived from DNase accessibility, ATAC‐
Seq data, conservation, FANTOM 5 CAGE, and motif analysis.
DNase‐Seq and ATAC‐Seq profiles were retrieved from ENCODE.
Conservation scores were generated from phyloP100way, phast-
Cons100way, and MultiZ alignments. Dinucleotide PWMs from
HOCOMOCO (Kulakovskiy et al., 2018) were used for the motif
analysis. SPRY‐SARUS and PERFECTOS‐APE (Vorontsov, Kulakovs-
kiy, Khimulya, Nikolaeva, & Makeev, 2019) were used to map motif
occurrences within reporter regions and to assess the difference of
motif P‐values for alternative alleles. “XGboost” and “LightGBM”
were used in multiclass prediction to determine the direction of
expression change.
Group 7: The set of features included DeepSEA scores (all 919),
DeepBind scores (all 515), ENCODE motifs, k‐mers (length 5),
number of unique motifs in a sequence, the density of unique motifs,
poly A/T, GC content, and conservation. An ensemble of five RF
classifiers and five “ExtraTreesClassifiers” with 1,000 trees. The
square root of total features was used to predict direction of change.
For continuous scores on promoters, again an ensemble of five RF
regressors and five “ExtraTreesRegressors” (with the same
parameters as above) was trained on the released training set. For
continuous scores on enhancers, an ensemble of one RF regressor,
one ExtraTreesRegressor (same parameters), and one gradient
boosting regressor with 1,000 boosting estimators) was trained on
the released training data.
5.1 | gkm‐SVM
We called MACS2 peaks after combining replicates of ENCODE2
(ENCODE Consortium, 2012), ENCODE3, and Roadmap (Roadmap
Epigenomics Consortium et al., 2015) human DHS, chromatin state, and
TF data for hg38 downloaded from the DCC (www.encodeproject.org).
We further separated enhancer (>2k from TSS) and promoter DHS and
chromatin peaks, and removed datasets with fewer than 2,500 enhancer
or promoter peaks, or fewer than 2,500 TF peaks (independent of
position). This yielded the following number of datasets for each
datatype: ENCODE2: (DHS.e, DHS.p, H3K27ac.e, H3K27ac.p,
H3K4me1.e, H3K4me1.p, H3K4me3.e, TF) = (159, 163, 20, 24, 17, 17,
35, 91, 345); ENCODE3: (DHS.e, DHS.p, H3K27ac.e, H3K27ac.p,
H3K4me1.e, H3K4me1.p, H3K4me3.e,TF) = (182, 196, 61, 67, 23, 23,
34, 68, 699); Roadmap: (DHS.e, DHS.p, H3K27ac.e, H3K27ac.p,
H3K4me1.e, H3K4me1.p, H3K4me3.e, TF) = (313, 317, 65, 98, 66, 63,
31, 173, 0), for a total of 3,350 training datasets. We extended +/−150bp
from each MACS2 summit, trained on 300bp regions, and ran gkm‐SVM
using parameters (‐l 11 ‐k 7 ‐d 3 ‐t 2) using the gkm‐SVM R‐package
(Ghandi et al., 2016) and ls‐gkm (Lee, 2016) for large training sets. All test
set AUROCs were high (median >0.9).
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